Afleveringen
-
Europe faces substantial challenges in continuing to deliver high-quality healthcare services to its citizens. With growing populations, rigid financing models and rising health inequalities, the conventional, reactive 'sick care' model needs to move to a more proactive, preventative and participatory model of care.
Without this transition, by 2040, European healthcare services will face being overwhelmed and unaffordable with diminished access, adversely affecting citizens' health and productivity.
Listen to episode 28 of the Life Sciences Connect Podcast to hear our guests dive into the most crucial questions from The Future of Health in Europe report.
-
In episode 27 of the Life Sciences Connect Podcast, we speak to the authors of the Time to Change report and discuss the current state of the UK healthcare workforce, touching on topics including pay, diversity, work-life balance, and training.
During our conversation, we explore the unrelenting challenges facing the UK’s healthcare workforce and share actionable, evidence-based solutions to help improve staff wellbeing, recruitment, and retention at a local level.
-
Zijn er afleveringen die ontbreken?
-
In Episode 26, our panel of industry experts dive into the key trends and challenges facing the consumer health industry. This is one not to miss.
With increased access to information, greater levels of choice and improved functionality of products and technology, consumers are increasingly taking a more proactive role in managing their own health. Tune in for our expert panel’s views on the future of the industry.
-
Tune in to the latest episode of the Life Sciences Connect podcast, where you will find Sara Siegel’s fireside chat about all things Global Healthcare
Episode 25 welcomes the new Global Head of Health and previous guest, Sara Siegel who discusses with Karen the various challenges impacting global healthcare systems today, their hopes and ambitions for the future.
-
Karen and the team explore the findings from the Future of Diagnostic Series
Episode 24 podcast explores some of the themes highlighted in our two reports on the future of diagnostics and specifically how the adoption of innovation and new models of service delivery are transforming diagnostic imaging.
-
Listen to episode twenty-three to hear Karen, and our guests dissect the findings from the latest annual R&D ROI Report which launched last month. This report has provided insights into the state of biopharma R&D since 2010. We have expanded the analysis over time and our data set now covers the top 20 pharma companies by R&D spend
-
In episode twenty-two, we explore the challenges facing UK government and public services. Tune in as our experts discuss the issues currently facing health and social care, from unsustainable levels of funding to longstanding pressures on the workforce.
Join Karen Taylor, Ed Roddis and Emma Horrell as they dissect the findings from the latest State of the State report to bring you a view of the state from the people who use and the people who run it: State of the State
-
On this episode of Life Sciences Connect podcast, we bring the discussion of emission reduction to the forefront. Hear our guest discuss further:
James Gregson – UK’s Life Sciences & Healthcare industry leader
At the start of October we launched our report: Embedding environmental sustainability into pharma’s DNA. In this episode of we explore the pressing challenges facing pharma in achieving ambitious environmental sustainability targets and evaluate ways of making progress through easy wins across the value chain, culture changes and new investment.
These quick wins can provide the license to make transformative, fundamental changes that are necessary to achieve pharma’s targets.
Listen to hear more on this topic.
-
On this episode of Life Sciences Connect podcast, we discuss these issues further with our panel of experts:
Andy Flockhart, UK MedTech Leader Guido Baechler, CEO of Mainz BiomedAnd of course, our host, Karen Taylor, Research Director, Centre for Health Solutions, Deloitte
Diagnostics play a pivotal role across the entire healthcare continuum from screening, detection and prognosis to patient stratification and condition monitoring
While diagnostics have always been one of the foundations of healthcare, advances in science and technology mean they are now well positioned to play a key role in revolutionising healthcare. Driving the need for innovation are growing and ageing populations, the increasing prevalence of non-communicable diseases and chronic conditions, workforce shortages and an increasingly knowledgeable and empowered consumer base
Listen to hear more on this topic.
-
Episode 19 of the Life Sciences Connect podcast sheds light on the important topic of Health equity and dives into discussions around what this really means, what businesses can do to improve this, how diversity groups are affected and much more. To learn more about health equity and other important issues facing public health in the UK, explore out Future of Public Health Series
-
Listen to episode 18 of the Life Sciences Connect podcast where we talk to specialists about Hospital Activation, how we are breaking from the traditional approach and what the future holds.
-
In episode sixteen of the Life Science Connect podcast, we dive into the conversation around our fourth report in our Future of Public Health series; Negating the gap - Preventing ill health and promoting healthy behaviours.
Joining our host Karen Taylor, Research Director of the Deloitte UK Centre for Health Solutions, is Dr Karen Kirkham, Chief Medical Officer and Lead Partner for Integration in Deloitte’s Health and Social Care team and Sara Siegel, Deloitte’s UK and EMEA Head of Healthcare as we examine the crucial role of public health in health protection, ill-health prevention and in promoting healthy behaviours.
Despite a wealth of evidence that investing in prevention is fundamental to a resilient and sustainable health system, the UK, like most other countries, spends less than five per cent of healthcare funding on preventative services. Listen to hear more about this debate and see what some of the experts have to say on this topic
-
In episode fifteen of the Life Science Connect podcast, we dive into the conversation around our annual R&D Measuring the return from pharmaceutical innovation series report. This report analyses the projected return on investment that biopharma companies can expect to earn from their late-stage pipelines.
-
In episode fourteen of the Life Science Connect podcast, we dive into the conversation around planetary health and sustainability in healthcare. Following COP26, it is important that we discuss points around the fundamental risk of climate change and how it impacts our health as well as healthcare delivery and its impact on climate.
On this episode of Life Science’s Connect podcast, we discuss these issues further with Deloitte experts on the panel, including:
James Gregson: Managing Partner, UK Life Sciences and Healthcare leader and Global Life Sciences and Healthcare ESG leader, Deloitte Lisa Dittmar: Manager, Deloitte’s Net Zero Transformation team, Monitor Deloitte Will Saddlington: Director in the consulting practice, DeloitteAnd of course, our host, Karen Taylor, Head of The Centre for Health Solutions, Deloitte
Our recent future of public health report series includes a report titled “Bridging the gap: Protecting the nation from public health threats”, where we highlight the issues of climate change and the fundamental threat it poses health as well as how healthcare delivery itself impacts the environment.
Visit the Life Sciences Connect Podcast homepage to discover more episodes.
-
In our thirteenth episode of the Life Science Connect podcast series, we discuss the findings from The Future of Public Health Series, covered in the overview report: Narrowing the gap: A fairer and more sustainable future for public health. This first instalment of the series summarises the key takeaways from our research of the challenges pre-pandemic, the impact of COVID-19 and the implications for the future for public health systems in the UK.
Joining our host Karen Taylor, Research Director of the Deloitte UK Centre for Health Solutions, is Karen Kirkham, Chief Medical Officer and Lead Partner for Integration in Deloitte’s Health and Social Care team and Cosima Pettinicchio, Director in Consulting in the Health and Social Care team.
-
In our twelfth episode of Life Sciences Connect, our host, Karen Taylor, the Research Director of the Centre for Health Solutions talks to Hanno Ronte, Partner at Monitor Deloitte about consumer research conducted this year on trust in the pharmaceutical industry and explores how COVID-19 has impacted trust, the perception and what role digital can play.
-
In our eleventh episode of Life Sciences Connect, we talk to Karen Taylor, Research Director of the Deloitte Centre for Health Solutions who is joined by Thomas Croisier, Consulting Partner, Deloitte France; Deborshi Dutt, Consulting Partner, Deloitte UK and Kristina Schapiro, Consulting Director, Deloitte UK to discuss how companies can use AI to improve drug launches and their commercial models.
Visit our Life Sciences Connect Podcast homepage to discover more episodes - https://www2.deloitte.com/uk/en/pages/life-sciences-and-healthcare/articles/life-sciences-connect.html
-
In our tenth episode of Life Sciences Connect, we talk to Karen Taylor, Research Director of the Deloitte Centre for Health Solutions who is joined by Naveed Panjwani, Director, Consulting, Deloitte and Kevin Dondarski, Senior Manager, Consulting, Deloitte US to discuss research and development.
Visit our Life Sciences Connect Podcast homepage to discover more episodes - https://www2.deloitte.com/uk/en/pages/life-sciences-and-healthcare/articles/life-sciences-connect.html
-
Our ninth episode of Life Sciences Connect series explores the key trends for the Medtech industry including the rise in consumer organisations entering the space, the evolution from product to service, the changing regulatory landscape, and the acceleration of MedTech in healthcare because of COVID-19.
Visit our Life Sciences Connect Podcast homepage to discover more episodes.
- Laat meer zien
